Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style Sc ...

Laboratory Corp (NYSE: LH) on Thursday reported second-quarter 2025 adjusted earnings per share of $4.35, up from $3.94 a year ago, beating the consensus of $4.17.Sales increased 9.5% year-over-year to $3.53 billion, beating the consensus of $3.485 billion.The increase was due to organic revenue growth of 5.4%, acquisitions, net of divestitures, of 3.5%, and foreign currency translation of 0.6%.Adjusted operating income for the quarter was $531.6 million, or 15.1% of revenue. Labcorp delivered double-digit ...

Labcorp Holdings (LH) Q2 2025 Earnings Call July 24, 2025 09:00 AM ET Company ParticipantsChristin O’Donnell - VP - Investor RelationsAdam Schechter - President, CEO, Chairman & DirectorJulia Wang - EVP & CFOKevin Caliendo - Managing DirectorPatrick Donnelly - Managing DirectorLisa Gill - Managing DirectorElizabeth Anderson - Senior MDTycho Peterson - MD - Global EquitiesLuke Sergott - Director - Healthcare Equity ResearchMichael Ryskin - Managing DirectorConference Call ParticipantsMichael Cherny - Senior ...

Labcorp Holdings (LH) Q2 2025 Earnings Call July 24, 2025 09:00 AM ET Speaker0Good day and thank you for standing by. Welcome to the Q2 twenty twenty five LabCorp Holdings Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone.You will then hear an automated message advising your hand is raised. To withdraw your question ...

Second Quarter 2025 Supplemental Financial Information 1 Use of Adjusted Measures The company has provided in this presentation and accompanying tables "adjusted" financial information that has not been prepared in accordance with GAAP, including adjusted net income, adjusted EBITDA, adjusted EPS (or adjusted net income per share), adjusted operating income, adjusted operating margin, free cash flow, and certain segment information. The company believes these adjusted measures are useful to investors as a s ...

Raises Full-Year Guidance BURLINGTON, N.C., July 24, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the second quarter ended June 30, 2025 and raised full-year guidance. "Labcorp had a very strong second quarter, delivering double-digit topline growth, while expanding margins across both segments," said Adam Schechter, chairman and CEO of Labcorp. "We brought innovative tests to market, and applied our leadership in s ...

Quest Diagnostics Inc. DGX delivered a robust second quarter in 2025, exceeding analyst expectations with strong sales and earnings growth, prompting an upward revision to its full-year guidance.However, the diagnostic test provider flagged potential headwinds from ongoing tariffs and the significant financial impact if the Protecting Access to Medicare Act (PAMA) is not deferred, setting the stage for a watchful eye on legislative and trade developments.For the second quarter of 2025, the company reported ...

Quest Diagnostics (DGX) Q2 2025 Earnings Call July 22, 2025 08:30 AM ET Company ParticipantsShawn Bevec - VP - IRJames Davis - Chairman, CEO, President & DirectorSam Samad - EVP & CFOKevin Caliendo - Managing DirectorElizabeth Anderson - Senior MDPatrick Donnelly - Managing DirectorNoah Kava - Equity Research AssociateConference Call ParticipantsAnn Hynes - MD & Senior Healthcare Services Equity AnalystErin Wright - AnalystMichael Cherny - Senior MD & Senior Research AnalystPito Chickering - AnalystJack Mee ...

Quest Diagnostics (DGX) Q2 2025 Earnings Call July 22, 2025 08:30 AM ET Speaker0Welcome to the Quest Diagnostics Second Quarter twenty twenty five Conference Call. At the request of the company, this call is being recorded. The entire contents of this call, including the presentation and question and answer session that will follow, are the copyrighted property of Quest Diagnostics with all rights reserved. Any redistribution, retransmission or rebroadcast of this call in any form without the written consen ...

Q2 2025 Performance Strong revenue growth from acquisitions, enterprise accounts, and innovative clinical solutions Q2 2025 15.2% Total revenue $2.76 billion 16.9% Adjusted operating income %2 11.5% Adjusted diluted EPS2 $2.62 per share 1 1,3 Company overview Quest is a leader in diagnostic testing insights and information services. Read our Q2 earnings press release on our Investor Relations site. " Through continued execution of our strategy, we delivered a strong second quarter, with revenues growing 15. ...